Shanghai Industrial Holdings Limited, an investment holding company, engages in the infrastructure facilities, medicine, consumer products, and real estate businesses. Segments The company conducts its operations through four segments, including Real Estate, Infrastructure Facilities, Medicine, and Consumer Products. Real estate This segment engages in the property development and investment and hotel operation. Infrastructure facilities This segment invests in toll road projects and water-related business. As of December 31, 2008, General Water of China had total assets of RMB5.2 billion, comprising 14 water projects and 19 water supply facilities, 17 sewage treatment facilities, 2 reservoirs and a pipe network of 1,841.27 kilometers. Medicine This segment engages in the manufacture and sale of medicine and health food; and medical equipment. The company produces human urine protein products. The company’s principal products include Kai Li Kang, a State Category I new drug, Ulinastatin, an exclusive brand in the domestic market, as well as certain raw pharmaceuticals for overseas markets. The company also engages in the production of basic pharmaceuticals used in urban communities and villages. Major products include Captopril Tablets and its raw pharmaceuticals, Compound Reserpine Tablets, Thalidomide Tablets and Compound Dihydralazine Sulfate Tablets. Consumer products This segment engages in the manufacture and sale of cigarettes, packaging materials, printed products, dairy products, commercial vehicles, automobile components, and spare parts. History Shanghai Industrial Holdings Limited was founded in 1996.
shanghai industrial hldg ltd
(363:Hong Kong Stock Exchange)
39 Gloucester Road
Phone: 852 2529 5652
Fax: 852 2529 5067www.sihl.com.hk
|Beijing Capital Co Ltd||CNY14.86 CNY||-0.58|
|Hyflux Ltd||$0.86 SGD||+0.025|
|Sembcorp Industries Ltd||$4.16 SGD||+0.01|
|View Industry Companies|
Sponsored Financial Commentaries
To contact SHANGHAI INDUSTRIAL HLDG LTD, please visit www.sihl.com.hk. Company data is provided by Capital IQ. Please use this form to report any data issues.